Paget's disease is a chronic condition which interferes with your body's normal bone remodeling process. ... Over time, the disease can cause affected bones to become fragile and misshapen. Paget's disease of bone most commonly occurs in the pelvis, skull, spine and legs.
This report contains market size and forecasts of Paget's Disease Treatment in Global, including the following market information:
Global Paget's Disease Treatment Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Paget's Disease Treatment market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Bisphosphonates Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Paget's Disease Treatment include Novartis AG, Mylan NV, Teva Pharmaceutical Industries Ltd., Neopharma, Inc., Sanofi S.A., Allergan(AbbVie), Fresenius Kabi, Sun Pharmaceutical Industries, Ltd. and Mallinckrodt Pharmaceuticals. etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Paget's Disease Treatment companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Paget's Disease Treatment Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Paget's Disease Treatment Market Segment Percentages, by Type, 2021 (%)
Bisphosphonates
Calcitonin Analogues (Salmon Calcitonin)
Analgesics
Calcium and Vitamin D Supplements
Global Paget's Disease Treatment Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Paget's Disease Treatment Market Segment Percentages, by Application, 2021 (%)
Hospitals
Clinic
Others
Global Paget's Disease Treatment Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Paget's Disease Treatment Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Paget's Disease Treatment revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Paget's Disease Treatment revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Novartis AG
Mylan NV
Teva Pharmaceutical Industries Ltd.
Neopharma, Inc.
Sanofi S.A.
Allergan(AbbVie)
Fresenius Kabi
Sun Pharmaceutical Industries, Ltd.
Mallinckrodt Pharmaceuticals